Private equity investments in health care raise several clinical and ethical questions about private equity’s influence on clinicians’ practices.

Dr Amber R. Comer joins Ethics Talk to discuss her article, coauthored with Dr Jake Young: “Physician Engagement With Private Equity Firms.”

Since its beginning, the AMA Journal of Ethics has grown into a distinct, editorially independent, peer-reviewed publication that illuminates complex questions and ideas often overlooked by traditional ethics curricula.

Some patients’ end-of-life care plans still require good antimicrobial management.

Dr Jeannie P. Cimiotti joins Ethics Talk to discuss her article, coauthored with Drs Kimberly Adams Tufts, Lucia D. Wocial, and Elizabeth Peter: “How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections?”

Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections.

This commentary on a case describes need for clinician collaboration to optimize therapeutic use of antimicrobials in clinical settings.

This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia.

Raising occupational consciousness and critically questioning ahistorical and apolitical uses of "battle" is needed for responding to antimicrobial resistance.

This article interrogates anthropocentrism and nonhuman animal instrumentalization in One Health.